Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial
| Title: | Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial |
|---|---|
| Authors: | Aygun, Banu *, Lane, Adam, Smart, Luke R, Santos, Brígida, Tshilolo, Léon, Williams, Thomas N, Olupot-Olupot, Peter, Stuber, Susan E, Tomlinson, George, Latham, Teresa, Ware, Russell E |
| Source: | In The Lancet Haematology June 2024 11(6):e425-e435 |
| Database: | ScienceDirect |
| ISSN: | 23523026 |
|---|---|
| DOI: | 10.1016/S2352-3026(24)00078-4 |
| Published in: | The Lancet Haematology |
| Language: | English |